Mergers & Acquisitions - Generics, Asia-Pacific


Current filters:


Popular Filters

Meiji Seika Pharma to acquire India’s Medreich for $290 million

Meiji Seika Pharma to acquire India’s Medreich for $290 million


Japan’s Meiji Seika Pharma revealed today that it intends to acquire all of the outstanding shares…

Asia-PacificGenericsMedreichMeiji Seika PharmaMergers & Acquisitions

Actavis forks out $100 million for Thai generics firm

Actavis forks out $100 million for Thai generics firm


Ireland-headquartered US generic major Actavis has acquired Silom Medical Company, a privately held generic…

Asia-PacificAurobindo PharmaGenericsMergers & AcquisitionsSilom Medical CompanyTeva Pharmaceutical Industries

Indian drugmakers readying for next “Patent cliff”


The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Actavis to shed another business, its Actavis Foshan unit in China

Actavis to shed another business, its Actavis Foshan unit in China


US generics major Actavis revealed a second divestiture this month, saying it has signed and completed…

ActavisAsia-PacificChinaGenericsMergers & AcquisitionsZhejiang Chiral

Alvogen takes 67% stake in Lotus Pharma


Privately-owned US generics firm Alvogen revealed that, last month, it agreed to become the majority…

AlvogenAsia-PacificGenericsLotus PharmaceuticalsMergers & Acquisitions

KKR acquires $200 million stake in India’s Gland Pharma

KKR acquires $200 million stake in India’s Gland Pharma


Indian injectable generic firm Gland Pharma says it has reached an agreement under which Kohlberg Kravis…

Asia-PacificGenericsGland PharmaMergers & Acquisitions

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed


US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Fresenius Kabi sets up JV for IV generics in Indonesia


Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million


US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal


The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Adcock Ingram closes Indian acquisition; Simcere sheds Shanghai Celgen stake


South Africa's largest health care company Adcock Ingram (AIP: SJ) has announced the completion of the…

Adcock IngramAsia-PacificCosme FarmaGenericsMergers & AcquisitionsShanghai Celgen Bio-PharmaceuticalsSimcere Pharmaceutical

Japan Pharma: Expectations for 2013, by P Reed Maurer


The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex


Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

No "Japan pharma for sale signs," by P Reed Maurer


Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves


Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Mylan buys Indian production unit from SMS Pharma for $33 million


Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

Pfizer launches generics JV in China with Hisun


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE Code: 600267), a leading…

Asia-PacificGenericsHisun-PfizerMergers & AcquisitionsPfizerPharmaceuticalZhejiang Hisun Pharma

CritiTech sets up JV with India's Finoso Pharma for APIs


USA-based CritiTech and privately-held Indian group Finoso Pharma have formally established a joint venture…

Asia-PacificCritiTechFinoso PharmaFinotech PharmaGenericsMergers & Acquisitions

Lilly to increase equity position in China's Novast by $20 million


US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities…

Asia-PacificEli LillyGenericsMergers & AcquisitionsNovast LaboratoriesPharmaceutical

Sigma-Aldrich acquires Research Organics; opens new facility in China


USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Kyowa Hakko sets up biosimilars joint venture with Fujifilm


Japanese digital camera and medical equipment conglomerate Fujifilm and drugmaker Kyowa Hakko Kirin have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyFujifilm Kyowa Kirin BiologicsGenericsHumiraKyowa Hakko KirinMergers & AcquisitionsResearch



Back to top